Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D’souza, Keith C.K. Lau, Carla S. Coffin, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 38, pp. 5759-5783
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 168
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Alessandro Vitale, Gianluca Svegliati‐Baroni, Alessio Ortolani, et al.
Gut (2021) Vol. 72, Iss. 1, pp. 141-152
Closed Access | Times Cited: 122
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 116
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 80
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 71
The role of interleukin-17 in inflammation-related cancers
Xingru Zhang, Bin Li, Lü Tian, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Virus-Mediated Cell-Cell Fusion
Héloïse Leroy, Mingyu Han, Marie Woottum, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9644-9644
Open Access | Times Cited: 98
Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
Pin Zhao, Samiullah Malik, Shaojun Xing
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
Ana Banko, Danijela Miljanovic, Andja Ćirković
International Journal of Infectious Diseases (2023) Vol. 130, pp. 108-125
Open Access | Times Cited: 23
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates
Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi Turyadi, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 120-134
Open Access | Times Cited: 12
From MASH to HCC: the role of Gas6/TAM receptors
Daria Apostolo, Luciana Louzada Ferreira, Federica Vincenzi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 10
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
Da Gong, Jian Mo, Mei Zhi Zhai, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Mechanisms underlining R-loop biology and implications for human disease
Junzhe Liu, Fengze Li, Yulong Cao, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Helicobacter pylori‐induced DNA double‐stranded break in the development of gastric cancer
Naoko Murata‐Kamiya, Masanori Hatakeyama
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1909-1918
Open Access | Times Cited: 38
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 21
Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga
Biochemical Pharmacology (2023) Vol. 215, pp. 115740-115740
Open Access | Times Cited: 20
Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma
Jiamin Gao, Zhijian Li, Qinchen Lu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18
A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis
Zijie Wu, Zehua Dong, Jiangti Luo, et al.
Genomics (2024) Vol. 116, Iss. 3, pp. 110831-110831
Open Access | Times Cited: 7
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods
Pinelopi Samara, Michail Athanasopoulos, Stylianos Mastronikolis, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1482-1482
Open Access | Times Cited: 7
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis
Mario Capasso, Valentina Cossiga, Maria Guarino, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1505-1505
Open Access | Times Cited: 6
The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases
Furkan Eker, Hatice Duman, Melih Ertürk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa
C. Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 11, pp. 1036-1048
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top